Stock Groups

CVS raises 2021 profit view as COVID-19 vaccines, tests drive retail strength -Breaking

[ad_1]

© Reuters. FILEPHOTO: A CVS Store in Manhattan, New York has shelves full cigarettes. This was taken February 5, 2014. REUTERS/Carlo Allegri

(Reuters) – CVS Health Corp (NYSE) raised Tuesday its adjusted earnings outlook for 2021. Strong retail sales were attributed to higher COVID-19 vaccination demand and over-the-counter testing results in November, December.

This company is best-known for its drugstore chain. It has raised its 2021 adjusted profit per stock forecast to $8.33-8.38 from $8.00.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of the potential risks and financial costs involved in trading in the financial market. It is among the most risky forms of investment.

[ad_2]